Foghorn Therapeutics Ownership 2024 | Who Owns Foghorn Therapeutics Now?
Institutional Ownership
62.58%
Insider Ownership
19.07%
Retail Ownership
18.35%
Institutional Holders
69.00
Foghorn Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 29.98% | 5.58% | 12,674,120 | - | - | 85,043,345 | Mar 31, 2024 |
| FMR LLC | 6.36% | 0.00% | 2,691,136 | -118,873 | -4.23% | 18,057,522 | Mar 31, 2024 |
| RAYMOND JAMES & ASSOCIATES | 5.28% | 0.01% | 2,230,456 | 162,069 | 7.84% | 14,966,360 | Mar 31, 2024 |
| EUCLIDEAN CAPITAL LLC | 3.72% | 1.35% | 1,573,761 | - | - | 10,559,936 | Mar 31, 2024 |
| BLACKROCK INC. | 3.11% | 0.00% | 1,315,371 | 9,503 | 0.73% | 8,826,140 | Mar 31, 2024 |
| VANGUARD GROUP INC | 2.61% | 0.00% | 1,102,493 | 77,380 | 7.55% | 7,397,727 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 1.70% | 0.12% | 720,720 | - | - | 4,836,031 | Mar 31, 2024 |
| ALPHABET INC. | 1.18% | 0.13% | 500,901 | - | - | 3,361,045 | Mar 31, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.06% | 0.00% | 448,411 | 61 | 0.01% | 3,009,185 | Mar 31, 2024 |
| STATE STREET CORP | 1.04% | 0.00% | 437,664 | 15,034 | 3.56% | 2,936,725 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.03% | 0.01% | 437,369 | -102,631 | -19.01% | 2,934,746 | Mar 31, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.76% | 1.76% | 320,930 | - | - | 2,153,440 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.66% | 0.02% | 280,382 | -63,338 | -18.43% | 1,881,363 | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.51% | 0.01% | 216,270 | 108,700 | 101.05% | 1,451,172 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.46% | 0.00% | 195,242 | -4,032 | -2.02% | 1,310,074 | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.29% | 0.24% | 121,672 | - | - | 816,419 | Mar 31, 2024 |
| COLONY GROUP, LLC | 0.25% | 0.01% | 107,770 | 107,770 | 100.00% | 632,000 | Mar 31, 2024 |
| ROCKWOOD WEALTH MANAGEMENT, LLC | 0.25% | 0.09% | 107,329 | -107,348 | -50.00% | 720,178 | Mar 31, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.24% | 0.00% | 100,305 | 3,288 | 3.39% | 673,047 | Mar 31, 2024 |
| MORGAN STANLEY | 0.18% | - | 74,970 | -30,143 | -28.68% | 503,049 | Mar 31, 2024 |
Foghorn Therapeutics's largest institutional shareholder is FLAGSHIP PIONEERING INC., holding 29.98% of the company's total share outstanding, currently valued at $85.04M. The top 10 institutional shareholders own together 56.04% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FLAGSHIP PIONEERING INC. | 29.98% | 5.58% | 12,674,120 | - | - | 85,043,345 | Mar 31, 2024 |
| BIRCHVIEW CAPITAL, LP | 0.76% | 1.76% | 320,930 | - | - | 2,153,440 | Mar 31, 2024 |
| EUCLIDEAN CAPITAL LLC | 3.72% | 1.35% | 1,573,761 | - | - | 10,559,936 | Mar 31, 2024 |
| SIO CAPITAL MANAGEMENT, LLC | 0.29% | 0.24% | 121,672 | - | - | 816,419 | Mar 31, 2024 |
| ALPHABET INC. | 1.18% | 0.13% | 500,901 | - | - | 3,361,045 | Mar 31, 2024 |
| ARTAL GROUP S.A. | 1.70% | 0.12% | 720,720 | - | - | 4,836,031 | Mar 31, 2024 |
| ALTA WEALTH ADVISORS LLC | 0.07% | 0.10% | 30,032 | - | - | 201,515 | Mar 31, 2024 |
| ROCKWOOD WEALTH MANAGEMENT, LLC | 0.25% | 0.09% | 107,329 | -107,348 | -50.00% | 720,178 | Mar 31, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | 0.06% | 0.03% | 25,819 | - | - | 173,245 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.66% | 0.02% | 280,382 | -63,338 | -18.43% | 1,881,363 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.03% | 0.01% | 13,448 | 13,448 | 100.00% | 90,236 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.05% | 0.01% | 21,855 | -19,440 | -47.08% | 147,000 | Mar 31, 2024 |
| RAYMOND JAMES & ASSOCIATES | 5.28% | 0.01% | 2,230,456 | 162,069 | 7.84% | 14,966,360 | Mar 31, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.11% | 0.01% | 47,097 | 25,562 | 118.70% | 316,021 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.03% | 0.01% | 437,369 | -102,631 | -19.01% | 2,934,746 | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.51% | 0.01% | 216,270 | 108,700 | 101.05% | 1,451,172 | Mar 31, 2024 |
| COLONY GROUP, LLC | 0.25% | 0.01% | 107,770 | 107,770 | 100.00% | 632,000 | Mar 31, 2024 |
| BAKER BROS. ADVISORS LP | 0.11% | 0.00% | 45,027 | - | - | 302,131 | Mar 31, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.24% | 0.00% | 100,305 | 3,288 | 3.39% | 673,047 | Mar 31, 2024 |
| FMR LLC | 6.36% | 0.00% | 2,691,136 | -118,873 | -4.23% | 18,057,522 | Mar 31, 2024 |
The largest Foghorn Therapeutics shareholder by % of total assets is FLAGSHIP PIONEERING INC.. The company owns 12.67M shares of Foghorn Therapeutics (FHTX), representing 5.58% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RAYMOND JAMES & ASSOCIATES | 5.28% | 0.01% | 2,230,456 | 162,069 | 7.84% | 14,966,360 | Mar 31, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0.51% | 0.01% | 216,270 | 108,700 | 101.05% | 1,451,172 | Mar 31, 2024 |
| COLONY GROUP, LLC | 0.25% | 0.01% | 107,770 | 107,770 | 100.00% | 632,000 | Mar 31, 2024 |
| VANGUARD GROUP INC | 2.61% | 0.00% | 1,102,493 | 77,380 | 7.55% | 7,397,727 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.15% | 0.00% | 62,047 | 62,047 | 100.00% | 416,335 | Mar 31, 2024 |
| INVESCO LTD. | 0.13% | 0.00% | 56,042 | 56,042 | 100.00% | 376,042 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.10% | 0.00% | 42,367 | 42,367 | 100.00% | 283,000 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.09% | 0.00% | 36,526 | 36,526 | 100.00% | 245,089 | Mar 31, 2024 |
| EXCHANGE TRADED CONCEPTS, LLC | 0.11% | 0.01% | 47,097 | 25,562 | 118.70% | 316,021 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.06% | - | 23,973 | 23,973 | 100.00% | 160,859 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.04% | - | 16,080 | 16,080 | 100.00% | 107,897 | Mar 31, 2024 |
| STATE STREET CORP | 1.04% | 0.00% | 437,664 | 15,034 | 3.56% | 2,936,725 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.03% | 0.01% | 13,448 | 13,448 | 100.00% | 90,236 | Mar 31, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.03% | 0.00% | 12,474 | 12,474 | 100.00% | 77,339 | Mar 31, 2024 |
| BLACKROCK INC. | 3.11% | 0.00% | 1,315,371 | 9,503 | 0.73% | 8,826,140 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.02% | - | 7,600 | 7,600 | 100.00% | 50,996 | Mar 31, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.14% | 0.00% | 60,769 | 3,571 | 6.24% | 407,761 | Mar 31, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.24% | 0.00% | 100,305 | 3,288 | 3.39% | 673,047 | Mar 31, 2024 |
| HSBC HOLDINGS PLC | 0.04% | 0.00% | 15,791 | 2,203 | 16.21% | 105,958 | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | - | 2,119 | 2,119 | 100.00% | 14,000 | Mar 31, 2024 |
As of Mar 31 2024, Foghorn Therapeutics's largest institutional buyer is RAYMOND JAMES & ASSOCIATES. The company purchased 162.07K stocks of FHTX, valued at $14.97M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FMR LLC | 6.36% | 0.00% | 2,691,136 | -118,873 | -4.23% | 18,057,522 | Mar 31, 2024 |
| ROCKWOOD WEALTH MANAGEMENT, LLC | 0.25% | 0.09% | 107,329 | -107,348 | -50.00% | 720,178 | Mar 31, 2024 |
| POINT72 ASSET MANAGEMENT, L.P. | 1.03% | 0.01% | 437,369 | -102,631 | -19.01% | 2,934,746 | Mar 31, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0.66% | 0.02% | 280,382 | -63,338 | -18.43% | 1,881,363 | Mar 31, 2024 |
| MORGAN STANLEY | 0.18% | - | 74,970 | -30,143 | -28.68% | 503,049 | Mar 31, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.05% | 0.01% | 21,855 | -19,440 | -47.08% | 147,000 | Mar 31, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.03% | - | 12,728 | -16,345 | -56.22% | 85,406,000 | Mar 31, 2024 |
| BARCLAYS PLC | 0.05% | - | 19,242 | -13,662 | -41.52% | 129,000 | Mar 31, 2024 |
| JANE STREET GROUP, LLC | - | - | - | -12,851 | -100.00% | - | Mar 31, 2024 |
| LAZARD ASSET MANAGEMENT LLC | 0.00% | - | 548 | -8,434 | -93.90% | 3,000 | Mar 31, 2024 |
| NORTHERN TRUST CORP | 0.46% | 0.00% | 195,242 | -4,032 | -2.02% | 1,310,074 | Mar 31, 2024 |
| UBS GROUP AG | 0.05% | - | 20,374 | -3,007 | -12.86% | 136,709 | Mar 31, 2024 |
| GOLDMAN SACHS GROUP INC | 0.03% | - | 11,421 | -2,820 | -19.80% | 76,635 | Mar 31, 2024 |
| AMALGAMATED BANK | 0.00% | - | 681 | -2,193 | -76.30% | 5,000 | Mar 31, 2024 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 0.00% | - | 2,044 | -1,302 | -38.91% | 13,715 | Mar 31, 2024 |
| TOWER RESEARCH CAPITAL LLC (TRC) | 0.00% | 0.00% | 394 | -1,133 | -74.20% | 2,644 | Mar 31, 2024 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 151 | -444 | -74.62% | 1,013 | Mar 31, 2024 |
| DEUTSCHE BANK AG\ | 0.02% | - | 9,594 | -399 | -3.99% | 64,376 | Mar 31, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -100 | -100.00% | - | Mar 31, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | 0.02% | 0.00% | 10,018 | -86 | -0.85% | 67,221 | Mar 31, 2024 |
As of Mar 31 2024, Foghorn Therapeutics's biggest institutional seller is FMR LLC. The company sold -0.12M shares of FHTX, valued at $18.06M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| COLONY GROUP, LLC | 0.25% | 0.01% | 107,770 | 107,770 | 100.00% | 632,000 | Mar 31, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.15% | 0.00% | 62,047 | 62,047 | 100.00% | 416,335 | Mar 31, 2024 |
| INVESCO LTD. | 0.13% | 0.00% | 56,042 | 56,042 | 100.00% | 376,042 | Mar 31, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.10% | 0.00% | 42,367 | 42,367 | 100.00% | 283,000 | Mar 31, 2024 |
| MARSHALL WACE, LLP | 0.09% | 0.00% | 36,526 | 36,526 | 100.00% | 245,089 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.06% | - | 23,973 | 23,973 | 100.00% | 160,859 | Mar 31, 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.04% | - | 16,080 | 16,080 | 100.00% | 107,897 | Mar 31, 2024 |
| XTX TOPCO LTD | 0.03% | 0.01% | 13,448 | 13,448 | 100.00% | 90,236 | Mar 31, 2024 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | 0.03% | 0.00% | 12,474 | 12,474 | 100.00% | 77,339 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.02% | - | 7,600 | 7,600 | 100.00% | 50,996 | Mar 31, 2024 |
| SIMPLEX TRADING, LLC | 0.01% | - | 2,119 | 2,119 | 100.00% | 14,000 | Mar 31, 2024 |
| CITADEL ADVISORS LLC | 0.00% | - | 1,400 | 1,400 | 100.00% | 9,394 | Mar 31, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | 3 | 3 | 100.00% | 20 | Mar 31, 2024 |
Foghorn Therapeutics's largest new institutional shareholder by number of shares is COLONY GROUP, LLC, purchased 107.77K shares, valued at $632.00K, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| JANE STREET GROUP, LLC | - | - | - | -12,851 | -100.00% | - | Mar 31, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | - | - | - | -100 | -100.00% | - | Mar 31, 2024 |
Foghorn Therapeutics's largest sold out institutional shareholder by shares sold is JANE STREET GROUP, LLC, sold -12.85K shares, valued at -, as of undefined.
Foghorn Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY MT VERNON STREET TRUST | 0.05% | 1,404,888 | -56,032 | -3.84% | Feb 29, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.03% | 5,601 | - | - | Dec 29, 2023 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 10,206 | - | - | Dec 31, 2023 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 2,986 | - | - | Dec 31, 2023 |
| ETFis Series Trust I | 0.01% | 8,258 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 36,217 | - | - | Dec 31, 2023 |
| VANGUARD INDEX FUNDS | 0.00% | 1,082,624 | 268,206 | 32.93% | Dec 31, 2023 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.00% | 505 | - | - | Dec 31, 2023 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 109,619 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 25,337 | 4,060 | 19.08% | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 215,973 | 10,442 | 5.08% | Feb 29, 2024 |
| GPS Funds I | 0.00% | 5,017 | - | - | Dec 31, 2023 |
| VICTORY PORTFOLIOS | 0.00% | 24,810 | - | - | Dec 31, 2023 |
| Calvert Variable Products, Inc. | 0.00% | 1,534 | - | - | Dec 31, 2023 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 13,954 | - | - | Dec 31, 2023 |
| OHIO NATIONAL FUND INC | 0.00% | 8,256 | - | - | Dec 31, 2023 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 9,020 | - | - | Dec 31, 2023 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,203 | - | - | Dec 31, 2023 |
| VANGUARD WORLD FUND | 0.00% | 62,061 | 320 | 0.52% | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 49,228 | 2,047 | 4.34% | Feb 29, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 30,201 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 410 | - | - | Dec 31, 2023 |
| Legg Mason ETF Investment Trust | 0.00% | 4,697 | - | - | Dec 31, 2023 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,000 | - | - | Dec 31, 2023 |
| LAZARD FUNDS INC | 0.00% | 2,735 | 2,735 | - | Dec 31, 2023 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,048 | - | - | Dec 31, 2023 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,084 | - | - | Feb 29, 2024 |
| iSHARES TRUST | 0.00% | 763,960 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 90,582 | 10,007 | 12.42% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 185 | - | - | Dec 31, 2023 |
| EQ ADVISORS TRUST | 0.00% | 46,663 | -10 | -0.02% | Dec 31, 2023 |
| ProFunds | 0.00% | 289 | 118 | 69.01% | Jan 31, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 2,487 | - | - | Dec 31, 2023 |
| PENN SERIES FUNDS INC | 0.00% | 800 | - | - | Dec 29, 2023 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 3,669 | -19 | -0.52% | Jan 31, 2024 |
| VALIC Co I | 0.00% | 7,801 | -32 | -0.41% | Feb 29, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 2,984 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 92 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 3,074 | - | - | Dec 31, 2023 |
| NORTHERN FUNDS | 0.00% | 19,661 | - | - | Dec 29, 2023 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 62,110 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 116 | - | - | Feb 29, 2024 |
| PROSHARES TRUST | 0.00% | 2,979 | -2,315 | -43.73% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 12 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 10,305 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 17,400 | - | - | Dec 31, 2023 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 784 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 2,303 | -9 | -0.39% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 4,859 | - | - | Jan 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 9,601 | - | - | Dec 31, 2023 |
| Brighthouse Funds Trust II | 0.00% | 7,279 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 6,606 | - | - | Dec 31, 2023 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 1,526 | - | - | Dec 31, 2023 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 2,367 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 3,591 | - | - | Dec 31, 2023 |
| Fidelity Rutland Square Trust II | 0.00% | 265 | 265 | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 4,200 | - | - | Feb 29, 2024 |
| John Hancock Funds II | 0.00% | 2,342 | - | - | Feb 29, 2024 |
Foghorn Therapeutics's largest mutual fund holder by % of total assets is "FIDELITY MT VERNON STREET TRUST", owning 1.40M shares, compromising 0.05% of its total assets.
Foghorn Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Mar, 24 | 69 | 18.97% |
| 31 Dec, 23 | 58 | -3.33% |
| 30 Sep, 23 | 60 | 3.45% |
| 30 Jun, 23 | 58 | -6.45% |
| 31 Mar, 23 | 62 | -6.06% |
| 31 Dec, 22 | 66 | 8.20% |
| 30 Sep, 22 | 61 | 7.02% |
| 30 Jun, 22 | 57 | -3.39% |
| 31 Mar, 22 | 59 | -6.35% |
| 31 Dec, 21 | 63 | 40.00% |
| 30 Sep, 21 | 45 | 21.62% |
| 30 Jun, 21 | 37 | -15.91% |
| 31 Mar, 21 | 44 | -2.22% |
| 31 Dec, 20 | 45 | - |
As of 31 Mar 24, 69 institutions are holding Foghorn Therapeutics's shares, representing an increase of 18.97% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Mar, 24 | 26,459,810 | 1.06% |
| 31 Dec, 23 | 26,182,775 | -2.64% |
| 30 Sep, 23 | 26,893,599 | 0.69% |
| 30 Jun, 23 | 26,708,734 | 1.78% |
| 31 Mar, 23 | 26,240,521 | 0.56% |
| 31 Dec, 22 | 26,095,422 | -0.81% |
| 30 Sep, 22 | 26,308,281 | 0.12% |
| 30 Jun, 22 | 26,276,871 | 5.51% |
| 31 Mar, 22 | 24,903,944 | 2.81% |
| 31 Dec, 21 | 24,222,929 | -0.24% |
| 30 Sep, 21 | 24,280,821 | 1.56% |
| 30 Jun, 21 | 23,908,851 | 2.52% |
| 31 Mar, 21 | 23,320,224 | 0.26% |
| 31 Dec, 20 | 23,258,739 | - |
Foghorn Therapeutics (FHTX) has 26.46M shares outstanding as of 31 Mar 24, up 1.06% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Mar, 24 | 62.58% | 1.61% |
| 31 Dec, 23 | 62.30% | 1.51% |
| 30 Sep, 23 | 64.30% | 1.58% |
| 30 Jun, 23 | 63.88% | 1.62% |
| 31 Mar, 23 | 62.76% | 1.59% |
| 31 Dec, 22 | 62.74% | 1.57% |
| 30 Sep, 22 | 63.13% | 1.58% |
| 30 Jun, 22 | 63.29% | 1.75% |
| 31 Mar, 22 | 60.20% | 1.42% |
| 31 Dec, 21 | 65.17% | 1.51% |
| 30 Sep, 21 | 65.67% | 1.56% |
| 30 Jun, 21 | 64.89% | 1.62% |
| 31 Mar, 21 | 63.34% | 0.45% |
| 31 Dec, 20 | 118.49% | - |
As of 31 Mar 24, Foghorn Therapeutics is held by 62.58% institutional shareholders, representing a 1.61% growth compared to 31 Dec 23.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 28 | 16.67% |
| 31 Dec, 23 | 24 | 33.33% |
| 30 Sep, 23 | 18 | -25.00% |
| 30 Jun, 23 | 24 | 4.35% |
| 31 Mar, 23 | 23 | -30.30% |
| 31 Dec, 22 | 33 | 26.92% |
| 30 Sep, 22 | 26 | -7.14% |
| 30 Jun, 22 | 28 | - |
| 31 Mar, 22 | 28 | -17.65% |
| 31 Dec, 21 | 34 | 70.00% |
| 30 Sep, 21 | 20 | -13.04% |
| 30 Jun, 21 | 23 | 53.33% |
| 31 Mar, 21 | 15 | -66.67% |
| 31 Dec, 20 | 45 | - |
28 institutional shareholders have increased their position in FHTX stock as of 31 Mar 24 compared to 24 in the previous quarter (a 16.67% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Mar, 24 | 18 | 12.50% |
| 31 Dec, 23 | 16 | -15.79% |
| 30 Sep, 23 | 19 | 26.67% |
| 30 Jun, 23 | 15 | - |
| 31 Mar, 23 | 15 | 36.36% |
| 31 Dec, 22 | 11 | -31.25% |
| 30 Sep, 22 | 16 | 14.29% |
| 30 Jun, 22 | 14 | -33.33% |
| 31 Mar, 22 | 21 | 31.25% |
| 31 Dec, 21 | 16 | 14.29% |
| 30 Sep, 21 | 14 | 366.67% |
| 30 Jun, 21 | 3 | -76.92% |
| 31 Mar, 21 | 13 | - |
| 31 Dec, 20 | - | - |
18 institutional shareholders have reduced their position in FHTX stock as of 31 Mar 24 compared to 16 in the previous quarter (a 12.50% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Mar, 24 | 69 | 18.97% | 26,459,810 | 1.06% | 62.58% | 1.61% | 28 | 16.67% | 18 | 12.50% |
| 31 Dec, 23 | 58 | -3.33% | 26,182,775 | -2.64% | 62.30% | 1.51% | 24 | 33.33% | 16 | -15.79% |
| 30 Sep, 23 | 60 | 3.45% | 26,893,599 | 0.69% | 64.30% | 1.58% | 18 | -25.00% | 19 | 26.67% |
| 30 Jun, 23 | 58 | -6.45% | 26,708,734 | 1.78% | 63.88% | 1.62% | 24 | 4.35% | 15 | - |
| 31 Mar, 23 | 62 | -6.06% | 26,240,521 | 0.56% | 62.76% | 1.59% | 23 | -30.30% | 15 | 36.36% |
| 31 Dec, 22 | 66 | 8.20% | 26,095,422 | -0.81% | 62.74% | 1.57% | 33 | 26.92% | 11 | -31.25% |
| 30 Sep, 22 | 61 | 7.02% | 26,308,281 | 0.12% | 63.13% | 1.58% | 26 | -7.14% | 16 | 14.29% |
| 30 Jun, 22 | 57 | -3.39% | 26,276,871 | 5.51% | 63.29% | 1.75% | 28 | - | 14 | -33.33% |
| 31 Mar, 22 | 59 | -6.35% | 24,903,944 | 2.81% | 60.20% | 1.42% | 28 | -17.65% | 21 | 31.25% |
| 31 Dec, 21 | 63 | 40.00% | 24,222,929 | -0.24% | 65.17% | 1.51% | 34 | 70.00% | 16 | 14.29% |
| 30 Sep, 21 | 45 | 21.62% | 24,280,821 | 1.56% | 65.67% | 1.56% | 20 | -13.04% | 14 | 366.67% |
| 30 Jun, 21 | 37 | -15.91% | 23,908,851 | 2.52% | 64.89% | 1.62% | 23 | 53.33% | 3 | -76.92% |
| 31 Mar, 21 | 44 | -2.22% | 23,320,224 | 0.26% | 63.34% | 0.45% | 15 | -66.67% | 13 | - |
| 31 Dec, 20 | 45 | - | 23,258,739 | - | 118.49% | - | 45 | - | - | - |
Foghorn Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Foghorn Therapeutics's stock was made by Cavalie Fanny on Mar 12 2024, selling 11,000 shares at $6.56 per share (valued at $72.13K).
Foghorn Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 1 | - | - |
| Q1 2024 | 6 | 1 | 600.00% |
| Q4 2023 | 1 | - | - |
| Q3 2023 | 3 | 3 | 100.00% |
| Q2 2023 | 9 | 1 | 900.00% |
| Q1 2023 | 9 | 2 | 450.00% |
| Q4 2022 | 2 | 1 | 200.00% |
| Q3 2022 | 3 | 13 | 23.08% |
| Q2 2022 | 12 | 1 | 1200.00% |
| Q1 2022 | 5 | 17 | 29.41% |
| Q4 2021 | 1 | 3 | 33.33% |
| Q3 2021 | 9 | 1 | 900.00% |
| Q2 2021 | 2 | 3 | 66.67% |
| Q1 2021 | 4 | - | - |
| Q4 2020 | 13 | 29 | 44.83% |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Foghorn Therapeutics's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | - | - |
| Q1 2024 | - | 1 | - |
| Q4 2023 | - | - | - |
| Q3 2023 | - | 1 | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | - | - | - |
| Q3 2022 | - | - | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | 5 | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Foghorn Therapeutics's stocks.
Foghorn Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ANEB | Anebulo Pharmaceuticals, Inc. |
| MLYS | Mineralys Therapeutics, Inc. |
| RZLT | Rezolute, Inc. |
| PMVP | PMV Pharmaceuticals, Inc. |
| CCCC | C4 Therapeutics, Inc. |
| CYT | Cyteir Therapeutics, Inc. |
| KYMR | Kymera Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| PRLD | Prelude Therapeutics Incorporated |
| IPSC | Century Therapeutics, Inc. |
| EWTX | Edgewise Therapeutics, Inc. |
| NRIX | Nurix Therapeutics, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| CSBR | Champions Oncology, Inc. |
| GLUE | Monte Rosa Therapeutics, Inc. |
| STTK | Shattuck Labs, Inc. |
| MOLN | Molecular Partners AG |
| MNOV | MediciNova, Inc. |
FHTX Ownership FAQ
Who Owns Foghorn Therapeutics?
Foghorn Therapeutics is owned by institutional shareholders (62.58%), insiders (19.07%), and public (18.35%). The largest institutional shareholder of Foghorn Therapeutics is FLAGSHIP PIONEERING INC. (29.98% of total shares) and the top mutual fund owner is FIDELITY MT VERNON STREET TRUST (0.05% of total shares).
Who are the major institutional shareholders of Foghorn Therapeutics?
Foghorn Therapeutics's major institutional shareholders are FLAGSHIP PIONEERING INC., FMR LLC, RAYMOND JAMES & ASSOCIATES, EUCLIDEAN CAPITAL LLC, and BLACKROCK INC.. The top five shareholders own together 48.45% of the company's share outstanding.
How many Foghorn Therapeutics shareholders are there?
As of Mar 2024, there are 69 institutional shareholders of Foghorn Therapeutics.
What percentage of Foghorn Therapeutics is owned by FLAGSHIP PIONEERING INC?
FLAGSHIP PIONEERING INC owns 12.67M shares of Foghorn Therapeutics, representing 29.98% of the company's total shares outstanding, valued at $85.04M (as of Mar 2024).
What percentage of Foghorn Therapeutics is owned by FMR LLC?
As of Mar 2024, FMR LLC holds 2.69M shares of Foghorn Therapeutics (FHTX), compromising 6.36% of the company, valued at $18.06M.
What percentage of Foghorn Therapeutics is owned by RAYMOND JAMES & ASSOCIATES?
RAYMOND JAMES & ASSOCIATES is the third largest holder of Foghorn Therapeutics. The company owns 2.23M of the company's shares outstanding (worth $14.97M).